| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/12/2004 | DE10225180A1 Protein oder Peptid (MIMPD), hierfür codierende Nukleinsäure sowie Verwendungen dieser Stoffe Protein or peptide (MIMPD), this encoding nucleic acid and uses of these substances |
| 02/12/2004 | CA2710100A1 Use of erythropoietin |
| 02/12/2004 | CA2497400A1 Diagnosis of kidney damage and protection against same |
| 02/12/2004 | CA2495556A1 Methods and kits for synthesis of sirna expression cassettes |
| 02/12/2004 | CA2495479A1 Antibacterial ester macrocycles |
| 02/12/2004 | CA2495478A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | CA2494868A1 Allele-specific sirna-mediated gene silencing |
| 02/12/2004 | CA2494859A1 Sirna-mediated gene silencing with viral vectors |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | CA2494348A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 02/12/2004 | CA2494311A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | CA2494308A1 Methods of use of compounds with preptin function |
| 02/12/2004 | CA2494305A1 Preptin methods of use |
| 02/12/2004 | CA2494276A1 Methods and reagents relating to inflammation and apoptosis |
| 02/12/2004 | CA2494212A1 Oral administration of calcitonin |
| 02/12/2004 | CA2493598A1 Use of erythropoietin_to treat renal failure |
| 02/12/2004 | CA2492497A1 Compositions, methods, and kits relating to behab and primary cns tumors |
| 02/11/2004 | EP1388544A1 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
| 02/11/2004 | EP1388537A1 Arginine derivatives |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387884A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387713A1 Method of preventing type 2 diabetes with aerosolized insulin |
| 02/11/2004 | EP1387692A2 Molecular interactions in hematopoietic cells |
| 02/11/2004 | EP1387691A1 Blood coagulation factor xiii for treating platelet disorders |
| 02/11/2004 | EP1387688A2 Benzazepinone alpha v integrin receptor antagonists |
| 02/11/2004 | EP1387684A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents |
| 02/11/2004 | EP1387681A2 Antiviral compounds |
| 02/11/2004 | EP1387674A2 Hedgehog antagonists, methods and uses related thereto |
| 02/11/2004 | EP1387660A1 Use of 3-position cyclosporin derivatives for hair growth |
| 02/11/2004 | EP1289544B1 Method for treating a movement disorder |
| 02/11/2004 | EP1157998B1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 02/11/2004 | EP1086113B1 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 02/11/2004 | EP1079808B1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 02/11/2004 | EP1028725B1 Use of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 02/11/2004 | EP1011712B1 Combination of cytokines having neurotrophic activity |
| 02/11/2004 | EP0961801B1 Monomers derived from hydroxy acids and polymers prepared therefrom |
| 02/11/2004 | EP0927042B1 Prevention of gastrointestinal damage |
| 02/11/2004 | EP0909177B1 Aqueous formulations of peptides |
| 02/11/2004 | EP0892640B1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0862615B1 Immunity against pasteurella haemolytica leukotoxin |
| 02/11/2004 | EP0859608B1 Treating niddm with rxr agonists |
| 02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 02/11/2004 | EP0835125B1 Cd4-derived peptides that inhibit immune responses |
| 02/11/2004 | EP0835124B1 Serum preparations for inhibiting retroviruses and tumor growth |
| 02/11/2004 | EP0804482B1 Cytokines that bind the cell surface receptor hek |
| 02/11/2004 | EP0655072B1 Immunological method for the detection of antibodies to equine herpesvirus type 1 and 4 glycoprotein G |
| 02/11/2004 | EP0506868B2 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474869A Novel compounds |
| 02/11/2004 | CN1474830A 修饰的凝血因子viii Modified coagulation factor viii |
| 02/11/2004 | CN1474704A Multipurpose packages for sterilized products or products to be sterilised |
| 02/11/2004 | CN1474685A Polymeric delivery formulations of leuprolide with improved efficacy |
| 02/11/2004 | CN1474683A Cosmetic and pharmaceutical composition and its use |
| 02/11/2004 | CN1474656A Improved bioactive whey protein hydrolysate |
| 02/11/2004 | CN1473935A GST fusion expression of conotoxin MVII A gene and its use |
| 02/11/2004 | CN1473931A Novel fermented soya beans streptokinase, its producing method and microbe for producing said streptokinase |
| 02/11/2004 | CN1473854A Recombined IL4 antibody for treating IL4 insertion diseases |
| 02/11/2004 | CN1473852A Trivalent chromium composition and its use |
| 02/11/2004 | CN1473848A Anti-tumor activity of Luffa acutangula 2 and its use |
| 02/11/2004 | CN1473847A Glycosidase activity of Luffa acutangula, and its use |
| 02/11/2004 | CN1473845A Polypeptide matter and its preparing method and use |
| 02/11/2004 | CN1473844A Polypeptide matter and its preparing method and use |
| 02/11/2004 | CN1473621A Medicinal new dosage form comtaining SA liposome as medicine carrier |
| 02/11/2004 | CN1473567A Combined therapeutic method including acrivastine and antihypertensive |
| 02/11/2004 | CN1473566A Combined therapeutic method including acrivastine and antihypertensive |
| 02/11/2004 | CN1138146C Method for detecting existence of anti-tissue transglutaminase antibody in body liquid externally |
| 02/11/2004 | CN1137898C Analogs of parathyroid hormone |
| 02/11/2004 | CN1137897C Process for preparing recombined human thrombopoietin preparation |
| 02/11/2004 | CN1137891C Process for preparing growth hormone cinogenic agent |
| 02/11/2004 | CN1137726C Method of prolonged suppression of humoral immunity |
| 02/11/2004 | CN1137724C Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction |
| 02/11/2004 | CN1137723C Enhanced wound coverage and composition to enhance wound healing |
| 02/11/2004 | CN1137722C Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens |
| 02/11/2004 | CN1137694C Method for preparing earthworm thrombus-dissolving enzyme injection for treating acute thrombus diseases |
| 02/11/2004 | CN1137688C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 02/11/2004 | CN1137680C Aerosol compositions |
| 02/11/2004 | CN1137677C Serine protease and topical retinoid composition |
| 02/10/2004 | USRE38424 Method for treating taxol side-effects with G-CSF |
| 02/10/2004 | US6689938 Administering an antagonist of melanocortin stimulating hormone (msh) biological activity. |
| 02/10/2004 | US6689878 Vaccine for preventing staphylococcus aureus infection |
| 02/10/2004 | US6689877 Administering a therapeutic amount of nebr1 antiretroviral transcriptional factor to hiv infected cells in patient |
| 02/10/2004 | US6689876 Cloning and sequencing of allergens of dermatophagoides |
| 02/10/2004 | US6689871 Process for production diphtheria toxin |
| 02/10/2004 | US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same |
| 02/10/2004 | US6689868 Isolated antibody which selectively binds to isolated cd2bp1 protein having specified amino acid sequence |
| 02/10/2004 | US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity |
| 02/10/2004 | US6689865 Nucleic acid molecules encoding DRT111 and uses thereof |
| 02/10/2004 | US6689864 Isolated polypeptide comprising cyclin dependent kinase 4 inhibitor or biologically active fragment thereof, encoded by dna molecule consisting of specified sequence |
| 02/10/2004 | US6689813 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects |
| 02/10/2004 | US6689807 Activating akt |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689775 Use of thioredoxin as, inter alia, a cell growth stimulator, as well as a screen for agents that are useful in reducing or eliminating thioredoxin-associated apoptosis inhibition and thioredoxin stimulated cell growth |
| 02/10/2004 | US6689763 Antibiotics AA-896 |
| 02/10/2004 | US6689762 Composition and methods for treatment of HIV infection |
| 02/10/2004 | US6689758 Treating wounds; using an early growth response-1 transcription factor polypeptide or fragment |